University of Rochester Strong Medical Center
Welcome,         Profile    Billing    Logout  
 4 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chang, Peter H
NCT06085079: Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study

Recruiting
4
20
US
Ixekizumab Prefilled Syringe
Massachusetts Eye Research and Surgery Institution, Eli Lilly and Company
Uveitis, Posterior, Uveitis, Anterior, Uveitis, Intermediate, Panuveitis
12/24
12/24
NCT06437223: Study of Xiflam™ Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long COVID (LC)

Recruiting
2
15
US
Tonabersat, Xiflam, Placebo
Inflammx Therapeutics Inc
Long COVID
03/25
06/25
LEOPARD, NCT05608837: Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects with Uveitis Related and Post Surgical Macular Edema

Recruiting
2
24
US
OCS-01, dexamethasone ophthalmic suspension eye drops
Quan Dong Nguyen, Global Ophthalmic Research Center (GORC), Oculis
Uveitis Related Cystoid Macular Edema, Cystoid Macular Edema, Postoperative
07/25
09/25
PROSTQA-RP2, NCT01325506: Effectiveness of Open and Robotic Prostatectomy

Completed
N/A
677
US
Questionnaire
Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, The Cleveland Clinic, Johns Hopkins University, University of California, San Francisco, University of Michigan, Vanderbilt University, Washington University School of Medicine, Emory University, Dana-Farber Cancer Institute
Prostate Cancer
10/24
10/24
PREVENT2, NCT04815876: PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2

Recruiting
N/A
1302
US
Transperineal MRI-guided prostate biopsy, Transrectal MRI-guided prostate biopsy, Antibiotic (prophylaxis)
Weill Medical College of Cornell University, Patient-Centered Outcomes Research Institute
Infection
06/25
06/25

Download Options